http://www.sciencemag.org/news/2016/12/ai-protein-folding-our-breakthrough-runnersProteins are life’s workhorses. They speed up vital chemical reactions, enable muscles to tug, carry out communication between and within cells, and defend against invaders. Given proteins’ talents, researchers have long wanted to create their own versions. They have modified many existing proteins by making small tweaks to an organism’s DNA code,
but this year,
they took protein modification
to a whole new level:
They created a suite of designer proteins unlike anything found in nature, setting the stage for novel medicines and materials.
[]
Recently, however, computational biologists have made heady progress in designing computer programs that accurately predict how designer proteins will fold. Those advances made possible this year’s
surge in designer proteins.
PROTEIN FOLDING IS HOT
AMICUSHot Performer of the day: Amicus Therapeutics, Inc. (NASDAQ:FOLD)FactsReporter-1 hour ago
Amicus Therapeutics, Inc. on 11/07/2016 reported its EPS as $-0.33 with the analysts projecting the EPS of the
stock as $-0.32. The company beat the analyst ...
Amicus Therapeutics Inc. (FOLD) Major Shareholder Buys ...Community Financial News-21 hours ago
Amicus Therapeutics Inc. (FOLD) Sees Significant Growth in Short ...BBNS-11 hours ago
PEREGRINEPeregrine Pharmaceuticals Inc. (PPHM) Stock Rating Upgraded by ...The Cerbat Gem-Dec 26, 2016
Peregrine Pharmaceuticals Inc. (NASDAQ:
PPHM) was upgraded by Zacks Investment ... has a $0.25 price objective on the biopharmaceutical company's
stock.
Insider Activity of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM)FactsReporter-Dec 27, 2016
Keep Track Of Active Stocks: Peregrine Pharmaceuticals Inc ...WsNews 4investors-Dec 27, 2016
Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) has the current ...The Newburgh Press-Dec 27, 2016
Broker Ratings: Zillow Group, Inc. (NASDAQ:Z), Peregrine ...Benchmark Monitor-Dec 27, 2016
PROTEOSTASISStock Holding Onto Its Positive Trend, Can The Positive Direction ...AR News-Dec 27, 2016
Proteostasis Therapeutics, Inc. (NASDAQ:
PTI) shares are holding above their moving averages, indicating a postitive uptrend for Technology company. In order ...
Proteostasis Therapeutics Inc. (PTI) Receives Average ...Community Financial News-Dec 26, 2016
Several research firms have recently commented on
PTI. HC Wainwright set a $15.00 target price on shares of Proteostasis Therapeutics and gave the
stock a ...
Stocks: Proteostasis Therapeutics Inc. (PTI) Major Shareholder ...DailyQuint-8 hours ago
Proteostasis Therapeutics Inc. (NASDAQ:
PTI) major shareholder Cormorant Asset Management, Ll acquired 327,977 shares of the
stock in a transaction dated ...
Tech Gainers: QuickLogic Corporation (NASDAQ:QUIK), Intelsat ...Benchmark Monitor-Dec 27, 2016
1 given Buy rating to the stock whereas no analyst given UNDERPERFORM rating to stock and ... rating to Proteostasis Therapeutics, Inc. (NASDAQ:
PTI)
stock.
Proteostasis Therapeutics Inc. (PTI) Soars 5.66% on December 26Equities.com-Dec 26, 2016
PTI - Market Data & News ·
PTI -
Stock Valuation Report. Proteostasis Therapeutics Inc. (PTI) had a good day on the market for Monday December 26 as shares ...
Investor Circle: Watching the Numbers on Shares of Proteostasis ...Wall Street Lion-18 hours ago
Currently, Proteostasis Therapeutics, Inc. (NASDAQ:
PTI)
ASTELLASOTC Wonder Stock Update: Focusing the Lens on ASTELLAS ...Duncan Research-Dec 27, 2016
ASTELLAS PHARMA INCORPORATED (ALPMF) has made news recently due to the fact that its share price changed -0.1, hitting $14.34 in the ...
Investor Sphere: Keeping an Eye on Levels for Astellas Pharma Inc ...Yankee Analysts-22 hours ago
Traders may be relying in part on technical
stock analysis.
Astellas Pharma Inc (ALPMY) currently has a 14-day Commodity Channel Index ...
IMMUNOMEDICSImmunomedics Announces Novel Immuno-Oncology Program ...Nasdaq-Dec 12, 2016
In a single-arm Phase 2 study,
IMMU-132 has produced promising results ... Dock-and-Lock
® (DNL
®)
protein conjugation platform technology.
Immunomedics Announces Achievement of Patient Enrollment Into ...GlobeNewswire (press release)-Dec 27, 2016
MORRIS PLAINS, N.J., Dec. 27, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (
NASDAQ:
IMMU) today announced that a single-arm Phase ...
Live Stock Coverage: Immucell Corp (NASDAQ:ICCC) Q3 2016 ...Post News-3 hours ago
Immucell Corp (
NASDAQ:ICCC) institutional sentiment increased to 1.6 in Q3 2016. ... The Firm has developed products that provide immediate
immunity ... birth) utilizing its vaccine and milk
protein purification technologies.
Time To Put On The Watch List? - Immunomedics, Inc. (NASDAQ ...The Voice Registrar-Dec 15, 2016
Immunomedics, Inc. (
NASDAQ:
IMMU) declined to $3.73 per share in the ... Dock-and-Lock
®(DNL
®)
protein conjugation platform technology.
Trading the Biotech News: Immunomedics, Inc. (NASDAQ:IMMU ...The Voice Registrar-Dec 16, 2016
Shares of Immunomedics, Inc. (
NASDAQ:
IMMU) added 0.27% by the end ... Dock-and-Lock
®(DNL
®)
protein conjugation platform technology.
CELEGENECelgene Corporation: CELG Stock Chart Setting Up for a SpikeProfit Confidential-Dec 26, 2016
Celgene Corporation (NASDAQ:CELG) stock is one of those investments that abides to technical indicators and patterns to such a degree that it ...
Stock's Earning Overview: Celgene Corporation (NASDAQ:CELG)News Oracle-Dec 21, 2016
Celgene Corporation (NASDAQ:CELG) Analyst EstimatesThe Independent Republic-Dec 27, 2016
Celgene Corporation (NASDAQ:CELG) stock is presently standing at about $118.93 and lots of equity research firms seem to have a target ...
Two Biotechnology Names Are Hot: OvaScience, Inc. (OVAS ...The Independent Republic-3 hours ago
Celgene Corporation (CELG) recently recorded -0.85 percent change and currently at $117.92 is 26.73 percent away from its 52-week low and ...
Brokers Watch List: Celgene Corporation (NASDAQ:CELG), MGIC ...The Newburgh Press-3 hours ago
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of ...
BMO Capital Remains Bullish On Celgene Corporation (CELG ...TCC-Dec 6, 2016
Why You Should Let Celgene Corporation Invest Your MoneyMotley Fool-Dec 7, 2016
That's the return that
Celgene Corporation (NASDAQ:CELG) achieved. But Celgene is a biotech, not an investment manager, right? Actually, it's ...
AMGEN1st Global Advisors Inc. Boosts Position in Amgen Inc. (AMGN)The Cerbat Gem-10 hours ago
Amgen logo 1st Global Advisors Inc. boosted its position in shares of
Amgen Inc.
Stocks: KAMES CAPITAL plc Reached $1352000 position of Amgen ...DailyQuint-2 hours ago
Biotech Stocks Worth a Closer Look: Amgen Inc. (NASDAQ:AMGN ...The Voice Registrar-1 hour ago
Shares of
Amgen Inc. (NASDAQ:AMGN) added 0.55% by the end of trading session at $148.36.
Analysts Take the Wheel on Amgen Inc. (NASDAQ:AMGN) Shares ...CSZ News-4 hours ago
Covering Street analysts are looking for
Amgen Inc. (NASDAQ:AMGN) to report quarterly EPS of $2.78.
poloniex.com
#foldingcion #curecoinPumper bot live on FLDC since Christmas and will continue indefinitely, turbo mode
Fractal interpolation of Sept 1-3 precursor wave (purple) behind Sept 8 to current (green) shakeout shows EASY 5X potential